×

Register now for access to the Parexel Biotech Content Hub

First Name
Last Name
Company Name
Job Title
Country
Thank you!
Error - something went wrong!
   

Crafting a genomics strategy early is key for successful oncology drug development

May 28, 2019

An historic shift towards treating cancer based on a tumor’s genetics rather than its site of origin is underway. Genomically-targeted drugs, properly developed, have an inherent advantage over drugs that are not. But the success of any one will depend on good strategic planning, done early. Read about three key considerations for crafting a successful genomic biomarker strategy.

Previous Flipbook
Oncology CoE brochure
Oncology CoE brochure

Building oncology trials for those who need them most.

Next Video
World Cancer Day Roundtable with Parexel Oncology Experts
World Cancer Day Roundtable with Parexel Oncology Experts

×

Speak to a Parexel® Biotech expert today!

First Name
Last Name
Job Title
Company Name
Country
Tell us how we can help
Thank you!
Error - something went wrong!